Javaeed, A., and S. K. Ghauri. “MCT4 Has a Potential to Be Used As a Prognostic Biomarker - a Systematic Review and Meta-Analysis”. Oncology Reviews, Vol. 13, no. 2, July 2019, doi:10.4081/oncol.2019.403.